Search research articles
Contact Us
Filters
Showing results (161-170 of 192) with videos related to
Page
of 20
Sort By:
Frontiers in Immunology
|
February 10, 2025
Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance
Santiago Rodríguez de Córdoba, Andrea Reparaz, Daniel Sanchez, et al.
JHEP Reports : Innovation in Hepatology
|
June 17, 2022
A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus
Nicolas Melin, Tural Yarahmadov, Daniel Sanchez-Taltavull, et al.
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Daniel Sanchez-Sotano, et al.
Nanoscale Advances
|
September 22, 2022
Engineered protein-based functional nanopatterned materials for bio-optical devices
Daniel Sanchez-deAlcazar, David Romera, Jose Castro-Smirnov, et al.
Cancers
|
May 4, 2026
Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing
Qian Nie, Kala F Schilter, Alexandra Larson, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2015
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma
Laura K Aguilar, Lawrence A Shirley, Vincent M Chung, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. <i>Curr. Oncol.</i> 2023, <i>30</i>, 6097-6110
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Molecular Cell
|
April 25, 2020
Absolute Quantification of Transcription Factors Reveals Principles of Gene Regulation in Erythropoiesis
Mark A Gillespie, Carmen G Palii, Daniel Sanchez-Taltavull, et al.
Nature Communications
|
December 17, 2021
Intraperitoneal microbial contamination drives post-surgical peritoneal adhesions by mesothelial EGFR-signaling
Joel Zindel, Jonas Mittner, Julia Bayer, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 192) with videos related to
Sort By:
Page
of 20
Frontiers in Immunology
|
February 10, 2025
Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance
Santiago Rodríguez de Córdoba, Andrea Reparaz, Daniel Sanchez, et al.
JHEP Reports : Innovation in Hepatology
|
June 17, 2022
A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus
Nicolas Melin, Tural Yarahmadov, Daniel Sanchez-Taltavull, et al.
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Daniel Sanchez-Sotano, et al.
Nanoscale Advances
|
September 22, 2022
Engineered protein-based functional nanopatterned materials for bio-optical devices
Daniel Sanchez-deAlcazar, David Romera, Jose Castro-Smirnov, et al.
Cancers
|
May 4, 2026
Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing
Qian Nie, Kala F Schilter, Alexandra Larson, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2015
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma
Laura K Aguilar, Lawrence A Shirley, Vincent M Chung, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. <i>Curr. Oncol.</i> 2023, <i>30</i>, 6097-6110
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Molecular Cell
|
April 25, 2020
Absolute Quantification of Transcription Factors Reveals Principles of Gene Regulation in Erythropoiesis
Mark A Gillespie, Carmen G Palii, Daniel Sanchez-Taltavull, et al.
Nature Communications
|
December 17, 2021
Intraperitoneal microbial contamination drives post-surgical peritoneal adhesions by mesothelial EGFR-signaling
Joel Zindel, Jonas Mittner, Julia Bayer, et al.
Page
of 20